| Financial Year |
March 31 2023 |
| Monetary Funds |
2,126,466,319.49 |
| Held-for-trading Financial Assets |
80,552,226.32 |
| Notes Receivable |
11,656,486.05 |
| Accounts Receivable |
1,155,207,689.18 |
| Advances to Suppliers |
44,770,129.19 |
| Other Receivables |
14,607,973.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,313,817,968.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
100,000,000.00 |
| Other Current Assets |
70,902,788.21 |
| Total Current Assets |
4,935,321,106.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,453,997.58 |
| Investment Properties |
75,854,424.87 |
| Fixed Assetes |
1,006,359,733.54 |
| Under-construction Projects |
156,311,896.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
223,193,590.85 |
| R&D expenses |
-- |
| Goodwill |
5,147,673.34 |
| Long-Term Deferred and Prepaid Expenses |
27,870,585.74 |
| Deferred Income Tax Assets |
108,902,103.01 |
| Other Non-Current Assets |
427,497,226.07 |
| Sub-Total of Non-Current Assets |
2,104,905,929.67 |
| Total Assets |
7,040,227,036.64 |
| Short-Term Loans |
64,375,503.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,220,911,247.38 |
| Accounts Payable |
1,134,885,734.85 |
| Accounts Received In Advance |
252,401.27 |
| Employee Compensation Payable |
103,205,243.32 |
| Taxes Payable |
149,013,289.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,034,482.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,339,971.77 |
| Other Current Liabilities |
14,568,800.22 |
| Sub-Total of Current Liabilities |
2,914,101,073.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
105,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
95,624,843.30 |
| Deferred Income Tax Liabilities |
609,187.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
269,870,783.44 |
| Total Liabilities |
3,183,971,857.24 |
| Paid-In Capital(Or Share Stock) |
582,445,394.00 |
| Capital Surplus |
503,422,270.01 |
| Surplus Reserve |
289,617,575.26 |
| LESS:Treasury Stock |
1,998,699.00 |
| Undistributed Profits |
2,433,280,917.32 |
| Minority Stockholder's Interest |
75,948,135.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,780,307,043.98 |
| Owner's Equity（Stockholder's Equity） |
3,856,255,179.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,040,227,036.64 |
